Development of hybrid microcarriers for stem cell therapy in COPD models ex vivo
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by an accelerated decline in lung function due to narrowing and fibrosis of small airways and irreversible alveolar tissue destruction termed as emphysema. To date, no effective treatments exist which can reverse the damaged state of the affected lungs. Stem cell therapy represents a promising approach for tar
